MIRA Pharmaceuticals | 10-Q: Quarterly report
MIRA Pharmaceuticals Sees Positive Trial Results for Ketamir-2
By Chris Wack MIRA Pharmaceuticals said it saw positive results in its trial for Ketamir-2, a novel oral ketamine analog that could potentially deliver ultra-rapid antidepressant effects. The pre-cl
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersMSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap stands at $15.9 million. Serina Therapeutics (AMEX:SER) stock moved up
Express News | Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year
Express News | Mira Pharmaceuticals Q4 EPS $(0.19) Beats $(0.23) Estimate
GOEV, CHEK and MESO Among Pre-market Losers
Press Release: MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor PR Newswire MIAMI, March 21, 2024 A seasoned pharmaceutical industry executiv
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersMolina Healthcare (NYSE:MOH) stock moved upwards by 24.2% to $503.11 during Wednesday's after-market session. The company's market cap stands at $29.3 billion. Evoke Pharma (NASDAQ:EVOK) shares
Mira Pharma Board Reshuffle Adds Scientific Expertise
In a strategic move to bolster its scientific acumen, Mira Pharma (NASDAQ: MIRA) announced the voluntary resignation of three board members last Thursday.
MIRA Pharmaceuticals Board Revamp and Strategic Advisory Hire
12 Health Care Stocks Moving In Friday's After-Market Session
GainersTalphera (NASDAQ:TLPH) shares moved upwards by 15.6% to $1.3 during Friday's after-market session. The company's market cap stands at $22.0 million. As per the news, the Q4 earnings report came
Medical Marijuana-Focused Mira Pharmaceuticals Stock Surges After Neuropsychiatric Disorders Update - Here's Why
Friday, Mira Pharmaceuticals Inc (NASDAQ:MIRA) disclosed a discovery regarding its pre-clinical drug candidate, MIRA1a. The company's current Report on Form 8-K unveils that what was previously believ
Trending Stocks Today: Safe & Green Development Soars 206.52%
March 8th - US stocks trending in regular trading hours.Gainers: $Safe & Green Development(SGD.US)$ surges 206.52% to $2.02 with a turnover of $43.61 million. $Psyence Biomedical(PBM.US)$ soars 178.06
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAinos (NASDAQ:AIMD) shares increased by 144.6% to $2.74 during Friday's pre-market session. The company's market cap stands at $12.8 million. Psyence Biomedical (NASDAQ:PBM) stock moved upwards
Trending Stocks Today: Ainos Surges 195.53% Pre-Market
March 8th - US stocks trending pre-market: Gainers: $Ainos(AIMD.US)$ surges 195.53% to $3.31 with a turnover of $11.93 million. $MIRA Pharmaceuticals(MIRA.US)$ soars 67.38% to $1.59 with a turnover of
MIRA Pharmaceuticals (MIRA) Surges In After-Hours Following Key Developments
In a sudden twist of events, MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) experienced a staggering 82% surge in its stock price during after-hours trading, almost doubling its value to an impressive $1.73. This significant leap comes on the heels of a rather subdued trading day where the stock showed minimal movement, slipping by a mere 0.1%. ...
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersSharps Technology (NASDAQ:STSS) stock increased by 27.9% to $0.37 during Tuesday's after-market session. The company's market cap stands at $5.6 million. DMK Pharmaceuticals (NASDAQ:DMK) stock
PRSO, AKRO and MIRA Among Pre-market Losers
Is MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans?
Express News | MIRA Pharmaceuticals Shares Are Trading Higher After the Company Announced a Research Collaboration With Pharmaseed to Research and Evaluate Ketamir for Patients With Major Depressive Disorder and Post-traumatic Stress Disorder
No Data